Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for early-stage investigators (postdoctoral researchers and early-career scientists) seeking to establish themselves as independent cancer researchers. The National Cancer Institute (NCI) Pathway to Independence Award (K99/R00) supports individuals with a doctoral degree (PhD, MD, DO, or equivalent) who are at a critical career transition point. The award typically funds cancer-related research projects that do NOT involve clinical trials. Applicants must be U.S. citizens, nationals, or permanent residents, and must be affiliated with an eligible institution. The K99 phase supports mentored research during the postdoctoral period (up to 2 years), while the R00 phase supports independent research upon faculty appointment (up to 3 years). This is a national competition open to researchers at academic medical centers, research institutes, and other NIH-eligible organizations.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NCI research support during this transition in order to help awardees to launch competitive, independent research careers.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Nonprofits
- Postdoctoral Researcher
- Private University
- Public Authority
- Public K-12 School
- Public University
- Researcher (independent)
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
How to apply
Application links
Required documents
- NIH Form SF-424 (R&R) - Application for Federal Research or Development Assistance
- Project Narrative (Specific Aims, Research Strategy, including significance, innovation, and approach)
- Biographical Sketch (NIH Form Page 5)
- Mentoring Plan and Mentor Biographical Sketch
- Transition to Independence Plan (detailing your pathway to faculty position)
- Budget and Budget Justification (K99 and R00 phases shown separately)
- Current and Pending Support documentation
- Institutional Commitment and Facilities documents
- Letters of Support from institution (for both K99 and R00 phases)
- Human Subjects and Animal Use documentation (if applicable)
- Conflict of Interest disclosures
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.398 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$23,853,515
-
$22,820,040
-
$17,454,036
-
$15,407,472
-
$14,832,927
-
$14,410,208
-
$14,234,718
-
$14,219,981
-
$13,766,537
-
$13,734,930
Top States by Funding
- CA 14 awards $114.6M
- MA 10 awards $104.9M
- TX 9 awards $102.7M
- NY 9 awards $65.8M
- NC 6 awards $62.1M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.398). How funding has trended year over year.
| 2024 | $228,173,992 | |
| 2025 | $213,201,522 | |
| 2026 est. | $135,455,000 |
FAQ
Who is eligible to apply for the K99/R00 award?
Postdoctoral researchers and early-career scientists with a doctoral degree (PhD, MD, DO, or equivalent) in cancer-related fields. You must be a U.S. citizen, national, or permanent resident, have a mentor at your institution, and meet specific career stage requirements (typically within 2-3 years of earning your degree or transitioning to postdoctoral status).
What types of research are supported?
Cancer-related research in basic science, translational research, clinical science, and epidemiology. Clinical trials are NOT allowed for this specific funding mechanism (K99/R00 Clinical Trial Not Allowed variant). Research must be original and scientifically sound.
What is the difference between the K99 and R00 phases?
The K99 phase (mentored period) supports up to 2 years of postdoctoral research training while you remain at your current institution. The R00 phase (independent period) provides up to 3 years of support after you secure an independent faculty position, allowing you to transition to independent research leadership.
When are deadlines, and how competitive is this award?
Standard NIH deadline is October 14, 2027 (fixed deadline). This is highly competitive; success rates typically range from 20-30%. Strong preliminary data, a clear research vision, and demonstrated productivity are essential.
What is the typical funding level?
The award typically provides substantial postdoctoral support ($65,000-$100,000+ annually depending on career stage and location) for the K99 phase, and similar or slightly higher support during the R00 phase. Actual amounts vary by institutional salary caps and NIH budget constraints.
💡 Tips for applicants
- Begin building relationships with a strong mentor at least 6-9 months before applying; your mentor's track record and commitment are critical to competitiveness.
- Develop preliminary data that demonstrates the feasibility and innovation of your proposed research; NIH reviewers expect concrete progress, not just theory.
- Be clear about your pathway to independence: show how you'll transition from mentored postdoctoral research to an independent faculty role, and identify realistic target institutions.
- Frame your project as significant and innovative within cancer research, but appropriately scoped for an early-career investigator; overambition without preliminary support will hurt your score.
- Pay careful attention to the "Clinical Trial Not Allowed" restriction: if your project involves clinical trial components, it will be administratively rejected. Clarify with your grants office if there is any ambiguity.
⚠️ Common mistakes
Applications often lack sufficiently robust preliminary data to demonstrate feasibility, or present a research plan that is too broad or insufficiently focused for the K99 phase. Another common issue is weak mentor commitment or mentoring plans that don't adequately address the transition to independence during the R00 phase. Applicants also sometimes propose projects with clinical trial elements unaware of the "Clinical Trial Not Allowed" restriction, leading to administrative rejection.
Similar grants
- OPEN NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) — National Institutes of Health
- OPEN NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed) — National Institutes of Health
- OPEN NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Required) — National Institutes of Health
- OPEN NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) — National Institutes of Health
- OPEN NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) — National Institutes of Health